Dentists in Rockford, MN Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Corey J Brenner, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 9000 Walnut St, Rockford, MN 55373 Phone: 763-477-5794 |
 Dr. Kacie Crowell Green, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8900 Walnut St # 459, Rockford, MN 55373 Phone: 763-477-5794 |
Dr. Randall E Herges, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6016 Main St, Rockford, MN 55373 Phone: 763-477-6273 Fax: 763-477-9693 |
Dr. Ann I Fromell-theis, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9000 Walnut Street, Rockford, MN 55373 Phone: 763-477-5794 Fax: 763-477-4784 |
News Archive
Thermo Fisher Scientific to acquire Phadia for €2.47 billion
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for €2.47 billion (or approximately $3.5 billion) in cash.
Healthy Lifestyles, Healthy Communities event to provide free medical, dental services in five cities
Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, announced today that Healthy Lifestyles, Healthy Communities will provide free medical and dental services to more than 5,000 children and their caregivers in five cities throughout the United States this summer and fall.
One of Australia's largest hospitals has suspected case of Creutzfeldt-Jakob Disease
The Royal Melbourne Hospital, one of Australia's largest hospitals, has contacted 1056 patients today after a man died of a suspected case of Creutzfeldt-Jakob Disease.
Initiation of Phase I/IIa clinical trial of IL-7 announced
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
› Verified 7 days ago
Dentists
Counselors
Clinical Social Workers
Occupational Therapists